Clinical Trials on 乙型肝炎,慢性 in Hong Kong
总计811个结果
-
Hoffmann-La Roche完全的
-
Hoffmann-La Roche终止
-
Humanity and Health Research CentreBeijing 302 Hospital; Nanfang Hospital of Southern Medical University招聘中
-
Humanity and Health Research CentreBeijing 302 Hospital完全的
-
NovartisNovartis Pharmaceuticals完全的
-
Hospital Authority, Hong KongThe University of Hong Kong未知
-
SCG Cell Therapy Pte. Ltd.招聘中
-
Enyo Pharma完全的
-
Hospital Authority, Hong KongVigconic (International) Ltd.完全的
-
United Christian HospitalPhilips Respironics; The Hong Kong Lung Foundation完全的
-
Brii Biosciences LimitedVir Biotechnology, Inc.主动,不招人
-
Humanity and Health Research CentreBeijing 302 Hospital; Nanfang Hospital of Southern Medical University; Yamanashi Prefectural Central...招聘中
-
Aligos Therapeutics终止
-
Hong Kong Baptist UniversityQueen Mary Hospital, Hong Kong; Princess Margaret Hospital, Hong Kong尚未招聘
-
Alnylam Pharmaceuticals终止乙型肝炎 | 慢性乙型肝炎 | 乙型肝炎,慢性 | 乙肝病毒 | 乙型肝炎感染英国, 新西兰, 新加坡, 大韩民国, 澳大利亚, 香港
-
Novartis PharmaceuticalsHuman Genome Sciences Inc.终止
-
Arrowhead Pharmaceuticals终止
-
Vir Biotechnology, Inc.Alnylam Pharmaceuticals完全的
-
Novira Therapeutics, Inc.完全的
-
Hoffmann-La Roche招聘中
-
Aligos Therapeutics招聘中慢性乙型肝炎香港, 中国, 英国, 摩尔多瓦共和国, 新西兰, 澳大利亚, 毛里求斯
-
Enyo PharmaParexel; Novotech (Australia) Pty Limited; Synteract, Inc.; Eurofins终止
-
Chinese University of Hong KongHenan Provincial People's Hospital完全的
-
The University of Hong KongHospital Authority, Hong Kong完全的End-stage Renal Failure (ESRF)香港
-
The Hong Kong Polytechnic UniversityHospital Authority, Hong Kong完全的